1)Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010; 122: 325-32
|
|
|
2)Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011; 57: 1181-9
|
|
|
3)Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. 2012; 33: 1105-11
|
|
|
4)Raatikainen MJ, Uusimaa P, van Ginneken MM, et al. Remote monitoring of implantable cardio-verter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace. 2008; 10: 1145-51
|
|
|
5)Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation. 2010; 122: 2359-67
|
|
|
6)Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366: 120-9
|
|
|
7)Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm. 2004; 1: 399-405
|
|
|
8)Messali A, Thomas O, Chauvin M, et al. Death due to an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2004; 15: 953-6
|
|
|
9)Veltmann C, Borggrefe M, Schimpf R, et al. Fatal inappropriate ICD shock. J Cardiovasc Elec-trophysiol. 2007; 18: 326-8
|
|
|
10)van Rees JB, Borleffs CJ, de Bie MK, et al. Inappropriate implantable cardioverter-defibril-lator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011; 57: 556-62
|
|
|
11)Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005; 112: 841-8
|
|
|
12)Vanderheyden M, Houben R, Verstreken S, et al. Continuous monitoring of intrathoracic imped-ance and right ventricular pressures in patients with heart failure. Circ Heart Fail. 2010; 3: 370-7
|
|
|
13)Maines M, Catanzariti D, Cirrincione C, et al. Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration. Europace. 2010; 12: 680-5
|
|
|
14)Catanzariti D, Lunati M, Landolina M, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol. 2009; 32: 363-70
|
|
|
15)Small RS, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associ-ated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail. 2009; 15: 475-81
|
|
|
16)Vollmann D, Nagele H, Schauerte P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J. 2007; 28: 1835-40
|
|
|
17)van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011; 124: 1719-26
|
|
|
18)Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J. 2011; 32: 2266-73
|
|
|
19)Klersy C, De Silvestri A, Gabutti G, et al. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol. 2009; 54: 1683-94
|
|
|
20)西井伸洋,伊藤 浩.チームで遠隔モニタリングを運用する.In: 伊藤 浩,監修.遠隔モニタリング実践マニュアル-植込み型デバイス活用術.東京: 文光堂; 2012
|
|
|